Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has been assigned a consensus rating of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company.

A number of research analysts recently issued reports on STVN shares. BNP Paribas started coverage on shares of Stevanato Group in a report on Monday. They issued an “outperform” rating for the company. Stephens restated an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a report on Monday, March 25th. Finally, Morgan Stanley restated an “equal weight” rating and set a $30.00 price target on shares of Stevanato Group in a report on Monday.

Stevanato Group Stock Up 2.6 %

Shares of Stevanato Group stock opened at €27.22 ($28.96) on Friday. The company has a current ratio of 1.50, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. Stevanato Group has a 12-month low of €23.00 ($24.47) and a 12-month high of €36.30 ($38.62). The firm’s 50-day moving average price is €30.29 and its two-hundred day moving average price is €29.48.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a net margin of 13.43% and a return on equity of 14.31%. The company had revenue of €320.60 million during the quarter, compared to analyst estimates of €326.85 million. During the same quarter in the previous year, the business posted $0.19 earnings per share. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, sell-side analysts predict that Stevanato Group will post 0.67 earnings per share for the current year.

Institutional Trading of Stevanato Group

Several hedge funds have recently bought and sold shares of STVN. Riverbridge Partners LLC acquired a new stake in Stevanato Group in the 3rd quarter valued at $21,272,000. Raymond James & Associates boosted its holdings in Stevanato Group by 0.9% during the 3rd quarter. Raymond James & Associates now owns 197,316 shares of the company’s stock worth $5,864,000 after acquiring an additional 1,806 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Stevanato Group during the 3rd quarter worth $255,000. Calamos Wealth Management LLC purchased a new position in Stevanato Group during the 3rd quarter worth $1,456,000. Finally, Conestoga Capital Advisors LLC boosted its holdings in Stevanato Group by 19.7% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 4,534,088 shares of the company’s stock worth $134,753,000 after acquiring an additional 746,136 shares during the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.